286 related articles for article (PubMed ID: 2783358)
1. Elevated plasma levels of the anaphylatoxins C3a and C4a are associated with a fatal outcome in sepsis.
Hack CE; Nuijens JH; Felt-Bersma RJ; Schreuder WO; Eerenberg-Belmer AJ; Paardekooper J; Bronsveld W; Thijs LG
Am J Med; 1989 Jan; 86(1):20-6. PubMed ID: 2783358
[TBL] [Abstract][Full Text] [Related]
2. [Atopic dermatitis. II. The status of complement proteins and the pathogenetic role of anaphylatoxins C4a, C3a and C5a].
Sergeev IuV; Reznikov IuP; Lobanova EV; Pimenova NS
Vestn Dermatol Venerol; 1989; (4):4-7. PubMed ID: 2788339
[TBL] [Abstract][Full Text] [Related]
3. Anaphylatoxin levels in human aqueous humor.
Mondino BJ; Sumner H
Invest Ophthalmol Vis Sci; 1986 Aug; 27(8):1288-92. PubMed ID: 3488296
[TBL] [Abstract][Full Text] [Related]
4. Demonstration of anaphylatoxins C3a, C4a and C5a in the scales of psoriasis and inflammatory pustular dermatoses.
Takematsu H; Ohkohchi K; Tagami H
Br J Dermatol; 1986 Jan; 114(1):1-6. PubMed ID: 3484631
[TBL] [Abstract][Full Text] [Related]
5. Determination of anaphylatoxin concentrations in suction blisters in patients with psoriasis.
Ohkohchi K; Takematsu H; Tagami H
J Invest Dermatol; 1986 Jul; 87(1):65-7. PubMed ID: 3487596
[TBL] [Abstract][Full Text] [Related]
6. Increased anaphylatoxins (C3a and C4a) in psoriatic sera.
Ohkohchi K; Takematsu H; Tagami H
Br J Dermatol; 1985 Aug; 113(2):189-96. PubMed ID: 3875363
[TBL] [Abstract][Full Text] [Related]
7. Anaphylatoxin generation in multisystem organ failure.
Heideman M; Hugli TE
J Trauma; 1984 Dec; 24(12):1038-43. PubMed ID: 6334754
[TBL] [Abstract][Full Text] [Related]
8. Complement activation and polymorphonuclear neutrophil leukocyte elastase in sepsis. Correlation with severity of disease.
Gardinali M; Padalino P; Vesconi S; Calcagno A; Ciappellano S; Conciato L; Chiara O; Agostoni A; Nespoli A
Arch Surg; 1992 Oct; 127(10):1219-24. PubMed ID: 1417490
[TBL] [Abstract][Full Text] [Related]
9. Involvement of complement in atopic dermatitis.
Kapp A; Schöpf E
Acta Derm Venereol Suppl (Stockh); 1985; 114():152-4. PubMed ID: 3923750
[TBL] [Abstract][Full Text] [Related]
10. C3, C5 components and C3a, C4a, and C5a fragments of the complement system.
Janatova J
Methods Enzymol; 1988; 162():579-625. PubMed ID: 3265757
[No Abstract] [Full Text] [Related]
11. Increased plasma levels of interleukin-6 in sepsis.
Hack CE; De Groot ER; Felt-Bersma RJ; Nuijens JH; Strack Van Schijndel RJ; Eerenberg-Belmer AJ; Thijs LG; Aarden LA
Blood; 1989 Oct; 74(5):1704-10. PubMed ID: 2790194
[TBL] [Abstract][Full Text] [Related]
12. Isolation of three separate anaphylatoxins from complement-activated human serum.
Hugli TE; Gerard C; Kawahara M; Scheetz ME; Barton R; Briggs S; Koppel G; Russell S
Mol Cell Biochem; 1981 Dec; 41():59-66. PubMed ID: 6977086
[TBL] [Abstract][Full Text] [Related]
13. Circulating complement proteins in patients with sepsis or systemic inflammatory response syndrome.
Stöve S; Welte T; Wagner TO; Kola A; Klos A; Bautsch W; Köhl J
Clin Diagn Lab Immunol; 1996 Mar; 3(2):175-83. PubMed ID: 8991632
[TBL] [Abstract][Full Text] [Related]
14. Generation of human C3a, C4a, and C5a anaphylatoxins by protein A of Staphylococcus aureus and immobilized protein A reagents used in serotherapy of cancer.
Langone JJ; Das C; Bennett D; Terman DS
J Immunol; 1984 Aug; 133(2):1057-63. PubMed ID: 6610702
[TBL] [Abstract][Full Text] [Related]
15. Complement activation from protamine sulfate administration after coronary angiography.
Click RL; Homburger HA; Bove AA
Cathet Cardiovasc Diagn; 1989 Apr; 16(4):221-5. PubMed ID: 2785004
[TBL] [Abstract][Full Text] [Related]
16. Complement profile in a C1 inhibitor deficient family.
Sayama K; Shiraishi S; Miki Y
Br J Dermatol; 1985 Dec; 113(6):737-43. PubMed ID: 4096884
[TBL] [Abstract][Full Text] [Related]
17. Involvement of complement in psoriasis and atopic dermatitis--measurement of C3a and C5a, C3, C4 and C1 inactivator.
Kapp A; Wokalek H; Schöpf E
Arch Dermatol Res; 1985; 277(5):359-61. PubMed ID: 3875319
[TBL] [Abstract][Full Text] [Related]
18. C4a anaphylatoxin levels as an indicator of disease activity in systemic lupus erythematosus.
Wild G; Watkins J; Ward AM; Hughes P; Hume A; Rowell NR
Clin Exp Immunol; 1990 May; 80(2):167-70. PubMed ID: 2357842
[TBL] [Abstract][Full Text] [Related]
19. Plasma anaphylatoxin concentrations in inflammatory skin diseases.
Terui T; Takematsu H; Kato T; Ohkohchi K; Tagami H
Tohoku J Exp Med; 1987 Feb; 151(2):245-52. PubMed ID: 3495048
[TBL] [Abstract][Full Text] [Related]
20. Complement activation in patients with primary antiphospholipid syndrome.
Oku K; Atsumi T; Bohgaki M; Amengual O; Kataoka H; Horita T; Yasuda S; Koike T
Ann Rheum Dis; 2009 Jun; 68(6):1030-5. PubMed ID: 18625630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
